(Q37954116)

25 August 2017

Disorders of blood pressure regulation-role of catecholamine biosynthesis, release, and metabolism (English)

1 reference

25 August 2017

4

1 reference

25 August 2017

Gemma Currie

1

1 reference

25 August 2017

E Marie Freel

series ordinal

2

1 reference

25 August 2017

Colin G Perry

series ordinal

3

1 reference

25 August 2017

language of work or name

1 reference

1 February 2012

1 reference

Current Hypertension Reports

25 August 2017

1 reference

25 August 2017

14

1 reference

25 August 2017

38-45

1 reference

25 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-011-0239-2

25 August 2017

0 references

cites work

Sympathectomy for hypertension; follow-up of 212 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Long-term stability of cardiovascular and catecholamine responses to stress tests: an 18-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Catecholamine biosynthesis and physiological regulation in neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Human tyrosine hydroxylase natural genetic variation: delineation of functional transcriptional control motifs disrupted in the proximal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Tyrosine hydroxylase polymorphism (C-824T) and hypertension: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Urocortin 2 lowers blood pressure and reduces plasma catecholamine levels in mice with hyperadrenergic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Human dopamine β-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Chromogranin A in human hypertension. Influence of heredity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Chromogranin A polymorphisms are associated with hypertensive renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Genetic regulation of catecholamine synthesis, storage and secretion in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Long human CHGA flanking chromosome 14 sequence required for optimal BAC transgenic "rescue" of disease phenotypes in the mouse Chga knockout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Effects of chromogranin A deficiency and excess in vivo: biphasic blood pressure and catecholamine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Chromogranin a and the autonomic system: decomposition of heart rate variability and rescue by its catestatin fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Direct vasoactive effects of the chromogranin A (CHGA) peptide catestatin in humans in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Chromogranin B: isolation from pheochromocytoma, N-terminal sequence, tissue distribution and secretory vesicle processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Autonomic function in hypertension; role of genetic variation at the catecholamine storage vesicle protein chromogranin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Common functional genetic variants in catecholamine storage vesicle protein promoter motifs interact to trigger systemic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

An introduction on TRP channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Sympathetic neural activity in hypertension and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Modulation of blood pressure by central melanocortinergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Changes in plasma lipids with psychosocial stress are related to hypertension status and the norepinephrine stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

The 'neuroadrenergic hypothesis' in hypertension: current evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Catecholamines regulate the activity, secretion, and synthesis of renalase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Sympathoadrenal medullary activity in young, spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0239-2

Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats

21 January 2018

1 reference

12 December 2020

Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice

1 reference

12 December 2020

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension

1 reference

12 December 2020

Plasma chromogranin A. Initial studies in human hypertension

1 reference

12 December 2020

Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome

1 reference

12 December 2020

TRP channels in disease

1 reference

12 December 2020

Hyperkinetic borderline hypertension in Tecumseh, Michigan

1 reference

12 December 2020

Biochemical evidence of sympathetic hyperactivity in human hypertension

1 reference

12 December 2020

Calcium and catecholamine interactions with adrenal chromogranins. Comparison of driving forces in binding and aggregation

1 reference

12 December 2020

10.1007/S11906-011-0239-2

Identifiers

DOI

1 reference

25 August 2017

1 reference